Classically, arthroscopy has been considered the diagnostic gold standard for assessing intra-articular knee abnormality.^[@bibr5-2325967119869846],[@bibr14-2325967119869846],[@bibr21-2325967119869846]^ Unfortunately, this diagnostic tool requires a surgical procedure. Magnetic resonance imaging (MRI) has been proposed as a valid tool for the diagnosis of intra-articular knee abnormality, especially in elderly patient populations, in whom surgical anesthesia carries significant risk.^[@bibr25-2325967119869846]^ Although MRI has been shown to be specific for meniscal and ligamentous injury, the sensitivity of MRI for identifying meniscal damage, or early stage chondral damage, is significantly less than that of traditional arthroscopy.^[@bibr2-2325967119869846]^ Other studies have highlighted differences between MRI and arthroscopy, further stating that the reliability of MRI to diagnose a complete anterior cruciate ligament tear had a sensitivity, specificity, accuracy, and negative predictive value (NPV) of 90.9%, 84.6%, 88.6%, and 84.6%, respectively.^[@bibr15-2325967119869846],[@bibr22-2325967119869846]^ The sensitivity, specificity, accuracy, and NPV of MRI to detect medial meniscal abnormality were 100%, 52.6%, 64%, and 100%, respectively, and to detect lateral meniscal abnormality they were 55.6%, 83.3%, 75.8%, and 83.3%, respectively.^[@bibr15-2325967119869846],[@bibr22-2325967119869846]^ The objective measures of test performance for MRI are not perfect by any means, leading experts to question its overall reliability while also seeking a superior method.^[@bibr11-2325967119869846]^

In-office arthroscopy has existed since the early 1990s; however, its use has been limited. Historically, the challenges associated with this technique included capital cost, procedural pain, time, lack of standardized surgical technique, and unclear literature concerning complications. All of these factors, combined with the relative ease of obtaining an MRI, have limited the growth of in-office arthroscopy as a diagnostic tool. However, improvements in technology, specifically the size and portability of the equipment and the quality of the images, has led to an insurgence in the use of in-office arthroscopy for diagnostic purposes, and recent work using in-office arthroscopy has been promising.^[@bibr17-2325967119869846],[@bibr9-2325967119869846]^

Although MRI is useful in the diagnosis of many intra-articular lesions, many patients have a contraindication to this imaging modality. For some patients, an MRI is contraindicated because of metallic implants, obesity, or claustrophobia. Additional drawbacks include the increased time and cost required for an MRI, including an additional visit to the MRI facility, a follow-up visit to the prescribing physician, and the risk of incidental findings.^[@bibr16-2325967119869846]^

An in-office diagnostic system enables clinicians to provide clinical solutions in an office-based setting. The ability to obtain intra-articular images for diagnostic purposes offers a statistically significant benefit compared with traditional MRI for the evaluation of intra-articular abnormality.^[@bibr6-2325967119869846],[@bibr9-2325967119869846]^ The potential cost savings associated with in-office arthroscopy are also worth noting. Voigt et al^[@bibr26-2325967119869846]^ demonstrated in 2014 that in-office arthroscopy procedures are responsible for a net saving of US\$151 million per year compared with traditional use of MRI.

The system used for the current study was the Trice Medical Mi-Eye2 ([Figure 1](#fig1-2325967119869846){ref-type="fig"}). The Mi-Eye2 consists of a disposable 14-gauge needle arthroscope and a handpiece that connects to a reusable portable tablet. This needle scope uses a "single-stick" mode of joint entry and allows for the 0° camera and light source to provide a 120° field of visualization, secondary to a retractable needle lumen after entry.

![The Mi-Eye2 system.](10.1177_2325967119869846-fig1){#fig1-2325967119869846}

The purpose of this retrospective series was to assess the risks and complications associated with in-office needle arthroscopy immediately during or after the procedure. These risks include but are not limited to infection, need for further imaging, systemic symptoms, and pain.

Methods {#section1-2325967119869846}
=======

A retrospective case series analysis was performed by evaluating consecutive diagnostic needle arthroscopies performed at 13 independent institutions by 13 physicians, all with experience in needle arthroscopy and selected by the senior author (N.H.A.). Procedures took place in an office setting during scheduled office hours. Although specific sterilization techniques differed among the surgeons included in this study, all of them performed sterile needle arthroscopy through a single needle stick using the Mi-Eye2 system. Data were collected from April 2016 through June 2018 for all diagnostic needle arthroscopies performed on the knee and shoulder. Although needle arthroscopy can be performed across all large joints, patients who had ankle, elbow, and wrist needle arthroscopies were excluded from this study. The patients' ages ranged from 14 to 78 years, and no statistical difference was noted between the numbers of men and women.

Major and minor complications associated with the procedure over a 2-year period were reviewed. A major complication was defined as an infection, chondral toxicity (rapid destruction of cartilage surfaces),^[@bibr7-2325967119869846],[@bibr13-2325967119869846],[@bibr24-2325967119869846]^ or the need for alternative treatment at an urgent care or emergency room secondary to the procedure. Minor complications included a vasovagal event, pain that persisted after 24 hours, and the need for crutches or sling after the procedure secondary to apprehension or pain. Additionally, the treating physicians documented the rationale for advanced imaging after the procedure ([Table 1](#table1-2325967119869846){ref-type="table"}).

###### 

Major and Minor Complications as Defined by the 13 Participating Physicians

![](10.1177_2325967119869846-table1)

  Major Complication                                        Minor Complication
  --------------------------------------------------------- ---------------------------------------------------------------------
  Infection                                                 Vasovagal episode
  Chondrotoxicity*^a^*                                      Pain lasting \>24 h or requiring narcotics
  Need for emergency department or urgent care evaluation   Need for crutches or sling postprocedure Need for MRI postprocedure

*^a^*Chondrotoxicity was defined previously in the literature as rapid chondrocyte death and progression of arthritis associated with intra-articular local anesthetic.^[@bibr7-2325967119869846],[@bibr13-2325967119869846]^ MRI, magnetic resonance imaging.

All the patients underwent a problem-based focused history and physical examination by the treating physician. Patients who had corroborating findings on history that pointed to intra-articular abnormality such as joint swelling, pain, mechanical symptoms, and positive provocative physical examination tests were indicated for the diagnostic needle arthroscopy using the Mi-Eye2 system. Signed consent was obtained from each patient prior to the procedure.

The aseptic preparation technique was documented for each individual surgeon ([Figure 2](#fig2-2325967119869846){ref-type="fig"}). The local anesthetic agent used on the skin and capsule, the length of time between numbing and the start of the procedure, and whether the numbing agent was intentionally placed in the joint were recorded. Additionally, patient positioning for the procedure was recorded. Also recorded was the method for entry into the joint (ie, whether a scalpel blade or trocar was initially used to create access to the joint, or whether the needle-scope was introduced into the joint with a single-stick method) ([Table 2](#table2-2325967119869846){ref-type="table"}).

![Example of aseptic preparation of a right knee by use of superolateral, medial, and lateral portal sites with alcohol and Betadine (Avrio Health).](10.1177_2325967119869846-fig2){#fig2-2325967119869846}

###### 

Breakdown of Each Physician's Mode of Entry Into the Joint, Technique for Closure, and Pre- and Postprocedure Antibiotic Regimens*^a^*

![](10.1177_2325967119869846-table2)

  Physician No.   Scalpel for Entry   Suture or Glue for Closure   Preprocedure Antibiotics   Postprocedure Antibiotics
  --------------- ------------------- ---------------------------- -------------------------- ---------------------------
  1               N                   N                            N                          N
  2               N                   N                            N                          N
  3               N                   N                            N                          N
  4               N                   N                            N                          N
  5               N                   N                            N                          N
  6               N                   N                            N                          N
  7               N                   N                            N                          N
  8               N                   N                            N                          N
  9               N                   N                            N                          N
  10              N                   N                            N                          N
  11              N                   N                            N                          N
  12              N                   N                            N                          N
  13              N                   N                            N                          N

*^a^*N, none given or used.

After the patient was anesthetized, the treating physician began the procedure via medial or lateral portal entry into the knee joint based upon the location of presumed abnormality, determined via prior physical examination, history, and clinical concern. Similarly, for the shoulder, entry into the joint was gained primarily through a posterior approach. However, entry through the rotator interval was used when the suspected abnormality was located along the posterior aspect of the glenohumeral joint. In some cases, the treating physician elected to use a probe to inspect the abnormality in greater detail, in which a separate entry was made after a sterile preparation, independent of the needle portal. Each physician performed a thorough investigation of the joint in question and documented the findings per his or her own medical record. At the conclusion of the procedure, a bandage and/or a small occlusive dressing was applied, and the patients were instructed to use ice and their choice of either a nonsteroidal anti-inflammatory drug or acetaminophen based upon the individual physician's postinjection protocol. Major and minor complications were noted and treated.

Results {#section2-2325967119869846}
=======

For this study, 1419 consecutive cases of diagnostic needle arthroscopy of the knee or shoulder were reviewed. Statistical analyses were performed on the outcome data from these cases. The findings of both major and minor complications were reported by each of the 13 surgeons based upon office documentation. The aggregate data were deidentified and collated in a secure encryption by the lead author (S.M.). The data were analyzed as a lump sum of both knee and shoulder cases and then subdivided and examined separately ([Table 3](#table3-2325967119869846){ref-type="table"}).

###### 

Sterile Technique, Number of Cases, Anesthetic Preparation, and Infections, Broken Down by Physician and Joint^*a*^

![](10.1177_2325967119869846-table3)

  Physician No.   Joint   No. of Cases                                            Standard Sterile Preparation Protocol                                                                                                                                                                     Standard Anesthetic Preparation Protocol                                                                                                               Infections
  --------------- ------- ------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------ ------------
  1               Knee    224                                                     Betadine swab sticks, then alcohol on sterile gauze for anesthetic, then repeat same for Mi-Eye2.                                                                                                         10-15 mL of 1% lidocaine for skin and capsule                                                                                                          0
  Shoulder        116     0                                                                                                                                                                                                                                                                                                                                                                                                                        
  2               Knee    137                                                     ChloraPrep                                                                                                                                                                                                15 mL total of 1% lidocaine/0.25% Marcaine                                                                                                             0
  Shoulder        7       ChloraPrep                                              30 mL total of 1% lidocaine/0.25% Marcaine                                                                                                                                                                0                                                                                                                                                      
  3               Knee    7                                                       ChloraPrep                                                                                                                                                                                                1% lidocaine: 5 mL anterolateral, 5 mL anteromedial, 10 mL suprapatellar per joint                                                                     0
  Shoulder        4       ChloraPrep                                              10 mL of 1% lidocaine, posterior approach                                                                                                                                                                 0                                                                                                                                                      
  4               Knee    187                                                     Betadine swab                                                                                                                                                                                             10 mL of 1% lidocaine with epinephrine in each portal                                                                                                  0
  Shoulder        4       10 mL of 1% lidocaine with epinephrine in each portal   0                                                                                                                                                                                                                                                                                                                                                                
  5               Knee    172                                                     Alcohol and ChloraPrep first (then infiltration tract). Next, cover the site and repeat preparation with ChloraPrep stick (no drapes).                                                                    20-30 mL of 1% lidocaine with 2 mL of bicarbonate                                                                                                      0
  Shoulder        51                                                              20-30 mL of 1% lidocaine with 2 mL of bicarbonate                                                                                                                                                         0                                                                                                                                                      
  6               Knee    22                                                      ChloraPrep                                                                                                                                                                                                5 mL of 1% lidocaine with epinephrine in each portal                                                                                                   0
  Shoulder        1                                                               5 mL of 1% lidocaine with epinephrine in each portal                                                                                                                                                      0                                                                                                                                                      
  7               Knee    5                                                       Gowned first and then preparation with hydrogen peroxide, followed by Betadine. Anesthetic given and allowed to set up for 10 min. Then another Betadine preparation with ethyl chloride for procedure.   10-15 mL of 1% lidocaine                                                                                                                               0
  Shoulder        82                                                              0                                                                                                                                                                                                                                                                                                                                                                
  8               Knee    39                                                      Chlorhexidine, sterile gloves, no drape.                                                                                                                                                                  10 mL of 1% lidocaine                                                                                                                                  0
  9               Knee    19                                                      Betadine swab sticks, then alcohol for Mi-Eye2 needle.                                                                                                                                                    Anesthetic: cold spray, 20 mL of 1% lidocaine without epinephrine in portals and joint                                                                 0
  10              Knee    127                                                     Betadine swab sticks, then alcohol on sterile gauze for anesthetic, then repeat same for Mi-Eye2.                                                                                                         20 mL total, half lidocaine 1%, half Marcaine 0.25% with epinephrine                                                                                   0
  Shoulder        9       Same as for knee                                        0                                                                                                                                                                                                                                                                                                                                                                
  11              Knee    50                                                      Iodine swab for injection of lidocaine-Marcaine mix followed by ChloraPrep and drape for the procedure.                                                                                                                                                                                                                                                          0
  Shoulder        6                                                               0                                                                                                                                                                                                                                                                                                                                                                
  12              Knee    56                                                      Alcohol followed by chlorhexidine preparation for injection, repeat chlorhexidine preparation for procedure, sterile gloves, no drapes.                                                                   Initial preparation with cold spray, then 15-20 mL of 1% lidocaine with epinephrine in skin and the track down to capsule; about 5 mL into the joint   0
  Shoulder        16      0                                                                                                                                                                                                                                                                                                                                                                                                                        
  13              Knee    74                                                      ChloraPrep swab, no drape.                                                                                                                                                                                8 mL of 1% lidocaine with epinephrine, 2-3 mL in capsule, minimal amount in joint                                                                      0
  Shoulder        4       0                                                                                                                                                                                                                                                                                                                                                                                                                        

*^a^*Manufacturers: Betadine, Avrio Health; ChloraPrep, Becton Dickinson and Co; Marcaine, Pfizer.

Of the 1419 cases, no major complications were reported. In particular, no cases of joint infections or trips to the urgent care and/or emergency department due to the procedure were reported. Upon secondary query of the investigating surgeons, no cases of superficial cellulitis around the needle arthroscopy site were reported, nor were there any known cases of chondral toxicity.

Minor complications are noted in [Table 4](#table4-2325967119869846){ref-type="table"}. The rate of overall vasovagal events was 1.9% for all procedures (1.6% for knees and 3% for shoulders). The incidence of persistent pain more than 24 hours postprocedure was 0.3%. The need for crutches or a sling postprocedure was 0%. The need for an MRI after diagnostic needle arthroscopy was overall 1.4%. The most common reason for ordering the MRI was inability to visualize the abnormality within the joint; per the physicians reporting, 55% of those cases occurred during the physicians' initial learning curve, defined as their first 15 cases. Other reasons for ordering an MRI were persistent pain despite a negative needle arthroscopy, looking for the presence of subchondral bone marrow edema based upon the needle arthroscopy findings, inability of the patient to tolerate the procedure, and mandate from 1 insurance carrier who did not recognize diagnostic needle arthroscopy as an acceptable form of diagnosis at the time of the procedure. Additional miscellaneous reporting included 2 cases of superficial ecchymosis around the portal sites and 1 patient receiving Plavix (Bristol-Myers Squibb Co, Sanofi SA) who had persistent bleeding from the procedure site requiring the addition of topical glue. No device failures were reported for either the tablet or the disposable handpiece. No statistical difference in minor complications was found between sexes.

###### 

Minor Complications and Patient Positioning, Broken Down by Physician and Joint*^a^*

![](10.1177_2325967119869846-table4)

  Physician No.   Joint   Cases, n                                      Standard Patient Positioning                                           Vasovagal, n   Persistent Pain (\>24 h), n            Need for Additional MRI, n
  --------------- ------- --------------------------------------------- ---------------------------------------------------------------------- -------------- -------------------------------------- ----------------------------
  1               Knee    224                                           Supine                                                                 3              0                                      4
  Shoulder        116     Lateral                                       0                                                                      0              1                                      
  2               Knee    137                                           Sitting                                                                5              0                                      2
  Shoulder        7       Sitting                                       0                                                                      0              0                                      
  3               Knee    7                                             Supine (knee flexed to 90°, extended, frog-leg standard)               0              0                                      0
  Shoulder        4       Sitting upright in examination chair          0                                                                      0              1                                      
  4               Knee    187                                           Seated with knee bent                                                  2              0                                      2
  Shoulder        4       Lateral, holding IV pole                      0                                                                      0              0                                      
  5               Knee    172                                           Supine                                                                 0              2                                      2
  Shoulder        51      Beach-chair                                   3                                                                                                                            
  6               Knee    22                                            Supine, then seated with knee bent                                     1              0                                      0
  Shoulder        1       Seated                                        0                                                                      0              0                                      
  7               Knee    5                                             Lateral                                                                1              0                                      0
  Shoulder        82      Beach-chair                                   3                                                                      0              0                                      
  8               Knee    39                                            Supine                                                                 1              0                                      2
  9               Knee    19                                            Supine                                                                 1              0                                      0
  10              Knee    127                                           Lying supine with legs flexed at knees, off end of examination table   2                                                     3
  Shoulder        9       Sitting upright at end of examination table   0                                                                      0              0                                      
  11              Knee    50                                            Supine                                                                 0              0                                      0
  Shoulder        6       Beach-chair                                   2                                                                      0              0                                      
  12              Knee    56                                            Seated                                                                 2              2, different from vasovagal patients   0
  Shoulder        16      Seated                                        0                                                                                     0                                      
  13              Knee    74                                            Supine                                                                 0              1                                      2
  Shoulder        4       2 seated, 2 lateral                           1                                                                      0              1                                      

*^a^*IV, intravenous; MRI, magnetic resonance imaging.

Discussion {#section3-2325967119869846}
==========

Over the past decade, the number of in-office diagnostic needle arthroscopy procedures has significantly increased, as the evolving technology allows physicians to visualize and accurately diagnose abnormalities. A multitude of factors have contributed to this increase, including patient demand, improved technologies, decreased delay in treatment, physician preference, and cost benefit to both the patient and the health care system. As the ability to diagnose intra-articular abnormality in the office setting becomes increasingly more common, the risks associated with diagnostic needle arthroscopy must be better understood. To our knowledge, this is the first study to critically evaluate the complications associated with in-office arthroscopy for the knee and shoulder joint.

Surgical arthroscopy has been considered the gold standard for intra-articular abnormalities associated with the knee and shoulder. However, it is not always prudent or possible to perform surgical diagnostic arthroscopy because of its inherent invasive nature, need for anesthesia, costliness, and other associated risks. In an effort to reproduce the information provided from surgical arthroscopy, diagnostic needle arthroscopy has increased in popularity.^[@bibr14-2325967119869846]^ In particular, pre- and postsurgical cartilage evaluation and postmeniscal repair have been strong indications for the procedure.^[@bibr4-2325967119869846]^ Chambers et al^[@bibr4-2325967119869846]^ noted that if the physician is unsure whether to order an MRI, it appears the value of the MRI is more unreliable. Other literature suggests that degenerative knee abnormality can be difficult to determine solely by MRI, and although MRIs provide some degree of information, they often do not add diagnostic value.^[@bibr1-2325967119869846]^ In addition to diagnostic difficulties noticed with MRI in this patient population, recent studies have shown a higher sensitivity and specificity in using needle-based arthroscopy versus MRI for the evaluation of meniscal abnormality.^[@bibr9-2325967119869846]^

Although previous literature on needle arthroscopy has focused on efficacy, our study focused on complications and overall safety. The results of this study demonstrate the safety of diagnostic needle arthroscopy as it pertains to both major and minor complications. Previously reported rates of infection for in-office needle arthroscopy were hypothesized to be similar to rates of infection for arthrocentesis (\<1 in 10,000).^[@bibr3-2325967119869846]^ However, to our knowledge, no large series has documented rates of infection or complication.^[@bibr8-2325967119869846][@bibr9-2325967119869846]--[@bibr10-2325967119869846]^

Our analysis demonstrated a 0% infection rate with a standard injection aseptic technique for a single-stick needle arthroscopy in 1419 patients. All closures were performed with simple bandages and/or a small compressive wrap. No scalpels were required for any incisions. The integrated system of the percutaneous camera and needle eliminates the need to make multiple passes within the joint, potentially reducing the risk of infections with a single-entry system.

The methods of anesthetizing the patients varied to some degree; however, a consensus was noted among the physicians that the use of lidocaine 1% with or without the addition of 0.25% Marcaine (Hospira) was sufficient to numb the skin and the capsule. Surgeons varied in their opinions regarding direct injection of a local anesthetic into the joint, and no cases of chondrotoxicity were reported followed during the 2-year study period. In addition, each surgeon attempted to remove all the residual fluid from the joint capsule at the end of the procedure to minimize nociceptor activation due to distention after the completion of the procedure. Each surgeon understood the potential risks associated with chondrotoxicity as reported by Kreuz et al.^[@bibr13-2325967119869846]^ They reported that minimal amounts of these agents will not pose a significant risk to cartilage, especially if sterile saline is used as an irrigant.^[@bibr13-2325967119869846]^

Understanding the potential risk for a vasovagal event is important. According to the physicians whose patients experienced a vasovagal event, only 3 of the 27 patients noted that the episode was due to pain. The majority of the patients reported that the episode occurred secondary to a phobia to needles or an "awkward sensation" during the procedure. The overall 1.9% rate of vasovagal events should be examined with the understanding that a subset of patients also cannot tolerate an MRI or MRI-arthrogram. The inability to tolerate an MRI for any reason has been reported to range between 0.7% and 20%.^[@bibr12-2325967119869846],[@bibr27-2325967119869846],[@bibr28-2325967119869846]^ To avoid the risk of a vasovagal event, the lead author has advocated placing the patient in a lateral position for shoulder needle arthroscopies and allowing the patient to lie either 45° or flat for knee arthroscopies. In addition to creating a comfortable office environment, it may be ideal to turn the tablet away from the patient's sight until the abnormality is identified. The terms used during the consultation with the patient are critical for patients with needle phobias; the term *needle scope* can be substituted with *small probe* or *camera*. This can help reduce anxiety in patients who may have a fear of needles.^[@bibr18-2325967119869846][@bibr19-2325967119869846]--[@bibr20-2325967119869846]^

Finally, the need for additional imaging was extremely low within this cohort of patients; 1.4% of the patients who underwent the needle arthroscopy required an additional MRI for further evaluation. Within the cohort of patients analyzed, the majority of the MRIs were ordered during the surgeon's early adaptation of the integrated system in the office. For investigation of shoulder labral injuries, knee or shoulder cartilage defects, or postsurgical reinjuries, a conventional MRI is often ordered and is often inconclusive.^[@bibr8-2325967119869846],[@bibr23-2325967119869846]^ As such, either a repeat MRI with the addition of arthrography or a surgical diagnostic evaluation is necessary to determine the true diagnosis. The realization that no single diagnostic tool is perfect or "always" indicated allows for further imaging should the treating physician deem it necessary. Additionally, challenges exist in creating a comfortable environment not only for the patient but also for the surgeon. Training and repetition will allow the clinician to become familiar with the 0° arthroscope and to avoid pitfalls such as "becoming entrapped in the fat pad."

Limitations {#section4-2325967119869846}
-----------

This was a multicenter retrospective study that evaluated in-office, needle-based diagnostic arthroscopy. Because of the retrospective nature of the study design, the results were dependent on the accuracy of the records kept as well as the patients' self-reporting of any nonacute complications. We realize that additional data points could have been obtained in a prospective randomized controlled study. Nevertheless, we were satisfied that the primary endpoint---demonstrating the safety of needle-based diagnostic arthroscopy---was achieved.

Conclusion {#section5-2325967119869846}
==========

Previous literature has evaluated the efficacy, sensitivity, and specificity of in-office diagnostic arthroscopy, and this study validates needle arthroscopy as safe in the office setting with minimal risk of major or minor complications.
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